Full Name
Zhidong Zhou
Variants
Zhou, Z
Zhou, Z.D
 
 
 
Email
gmszz@nus.edu.sg
 

Publications

Refined By:
Date Issued:  [2010 TO 2019]

Results 1-13 of 13 (Search time: 0.009 seconds).

Issue DateTitleAuthor(s)
12015Association analysis of COQ2 variant in dementia and essential tremorChao Y.X. ; Ng E.Y.L.; Li H. ; Nagaendran K. ; Yih Y. ; Chong M.S.; Prakash K.M. ; Tan L. ; Au W.L. ; Zhao Y.; Zhou Z.D. ; Tio M.; Pavanni R. ; Tan E.K. 
22-Dec-2016Dopamine (DA) Dependent Toxicity Relevant to DA Neuron Degeneration in Parkinson’s Disease (PD)Zhou, Zhidong ; Thevapriya, Selvaratnam; Chao, Yin Xia; Lim, Tit Meng ; Tan, Eng King 
316-Oct-2017Dopamine (DA) toxicity in pathogenesis and therapy of Parkinson’s disease (PD)Zhou, Zhidong ; Tan, Eng King 
42017Erratum to: Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative Diseases (Molecular Neurobiology, (2017), 54, 7, (5534-5546), 10.1007/s12035-016-0099-5)Zhou Z.-D. ; Saw W.-T.; Tan E.-K. 
5Nov-2010Glutathione conjugates with dopamine-derived quinones to form reactive or non-reactive glutathione-conjugatesZhou, Z.D. ; Lim, T.M. 
615-Dec-2010Iron species-mediated dopamine oxidation, proteasome inhibition, and dopaminergic cell demise: Implications for iron-related dopaminergic neuron degenerationZhou, Z.D. ; Lan, Y.H.; Tan, E.K. ; Lim, T.M. 
72017LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stressChen Z. ; Cao Z.; Zhang W.; Gu M. ; Zhou Z.D. ; Li B.; Li J.; Tan E.K. ; Zeng L. 
82017Mitochondrial CHCHD-Containing Proteins: Physiologic Functions and Link with Neurodegenerative DiseasesZhou Z.-D. ; Saw W.-T.; Tan E.-K. 
9Mar-2014Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neuronsZhou, Zhidong ; Refai, Fathima Shaffra; Xie, Shao Ping; Ng, Shin Hui; Chan, Christine Hui Shan; Ho, Patrick Ghim Hoe; Zhang, Xiao Dong; Lim, Tit Meng ; Tan, Eng King 
102017Phosphorylation of amyloid precursor protein by mutant LRRK2 promotes AICD activity and neurotoxicity in Parkinson's diseaseChen Z.-C. ; Zhang W.; Chua L.-L. ; Chai C. ; Li R.; Lin L.; Cao Z.; Angeles D.C. ; Stanton L.W. ; Peng J.-H.; Zhou Z.-D. ; Lim K.-L. ; Zeng L. ; Tan E.-K. 
1128-Mar-2017Potential Implications of Mitochondrial Unfolded Protein Response in the Pathogenesis and Therapy of Dopaminergic Neuron Degeneration in Parkinson’s Disease.Zhou, Zhidong ; Chao, Yin Xia; Tan, Eng King 
1216-Aug-2019The Therapeutic Implications of Tea Polyphenols against Dopamine (DA) Neuron Degeneration in Parkinson's Disease (PD)Zhou, Zhidong ; Xie, Shao Ping; Saw, Wuan Ting; Ho, Patrick Ghim Hoe; Wang, Hong Yan; Zhou, Lei ; Zhao, Yi; Tan, Eng King 
132017Varied pathological and therapeutic response effects associated with CHCHD2 mutant and risk variantsTio M. ; Wen R.; Lim Y.L.; Zukifli Z.H.B.; Xie S. ; Ho P.; Zhou Z. ; Koh T.-W. ; Zhao Y.; Tan E.-K.